Sangamo Biosciences reported $73.49M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amgen AMGN:US $ 3.74B 804M
Avrobio Inc AVRO:US 29.42M 1.46M
Bayer BAYN:GR 10.43B 1.33B
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
IONIS PHARMACEUT IONS:US $ 199.42M 19.98M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Merk MRK:US $ 10332M 386M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Regulus Therapeutics RGLS:US $ 6.57M 391K
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
Ziopharm Oncology ZIOP:US $ 9.08M 1.97M